Key Moments
#87—Rick Johnson, MD: Fructose—the common link in hypertension, insulin resistance, T2D, & obesity?
Peter Attia MDKey Moments
Fructose metabolism drives metabolic syndrome, obesity, diabetes, and hypertension via uric acid and energy depletion.
Key Insights
High salt intake can trigger endogenous fructose production by activating an enzyme that converts glucose to fructose, contributing to hypertension.
Fructose metabolism uniquely depletes cellular ATP and phosphate, activating AMP deaminase and promoting fat storage, insulin resistance, and uric acid production.
A genetic mutation in uricase, which occurred millions of years ago, made humans more sensitive to fructose, contributing to our predisposition to metabolic diseases.
Elevated uric acid, often a byproduct of fructose metabolism, is a significant risk factor for hypertension, kidney disease, insulin resistance, and metabolic syndrome.
Drinking fluids with sugar, particularly soft drinks, is more detrimental than eating solid sugars due to rapid absorption and high liver concentration of fructose.
While whole fruits contain beneficial nutrients that can mitigate some fructose effects, excessive consumption, especially of high-fructose fruits, can still contribute to metabolic issues.
THE CONNECTION BETWEEN SALT AND HIGH BLOOD PRESSURE
Initially a kidney doctor, Dr. Rick Johnson's research into high blood pressure unexpectedly led him to fructose. While salt has long been associated with hypertension, recent findings suggest that it's not the amount of salt, but how it affects serum osmolality (concentration) that triggers a transient rise in blood pressure. High salt intake can activate an enzyme in the body that converts glucose to fructose, which then contributes to further metabolic dysfunction and elevated blood pressure.
FRUCTOSE METABOLISM AND ITS ENERGY DEPLETION EFFECT
Unlike glucose, which is primarily used for energy production, fructose metabolism has a unique effect on cellular energy. When fructose is metabolized, it triggers an unregulated consumption of ATP (cellular energy currency) and intracellular phosphate. This significant drop in energy signals the body to conserve energy, store it as fat, and become insulin resistant, effectively preparing it for periods of scarcity.
THE ROLE OF URIC ACID IN METABOLIC SYNDROME
A key byproduct of fructose metabolism is uric acid. Elevated uric acid levels, beyond their association with gout, are now understood to be a significant driver of key metabolic syndrome characteristics. Uric acid promotes oxidative stress, contributing to mitochondrial dysfunction, insulin resistance, hypertension, and fatty liver disease, and can even be detrimental to pancreatic islet cells.
EVOLUTIONARY ORIGINS OF FRUCTOSE SENSITIVITY
Around 12-15 million years ago, a mutation in the uricase enzyme occurred in ancestral apes, making them more efficient at converting fructose into fat and increasing uric acid production. This mutation was likely a survival advantage during periods of food scarcity, allowing for better fat and water storage. However, this evolutionary adaptation also made humans uniquely susceptible to the metabolic consequences of abundant fructose in modern diets.
IMPACT OF DIETARY CHOICES: LIQUIDS VS. SOLIDS, AND ARTIFICIAL SWEETENERS
The form in which fructose is consumed significantly impacts its metabolic effects. Drinking sugary beverages delivers a concentrated dose of fructose rapidly to the liver, exacerbating ATP depletion and uric acid production more than consuming the same amount of fructose in solid form. While artificial sweeteners are generally considered a lesser evil than sugar due to their lack of caloric content, potential long-term effects on gut microbiota and metabolism are still being studied.
THE COMPLEXITY OF CANCERS AND OTHER METABOLIC DISORDERS
Fructose's ability to promote survival in low-oxygen environments, partially due to its shift towards glycolysis, makes it a preferred fuel source for many cancer cells. By blocking fructokinase, the enzyme responsible for initial fructose metabolism, the growth and spread of various cancers can be significantly inhibited. Furthermore, fructose metabolism, particularly the AMPD pathway, is implicated in neurological disorders like Alzheimer's, highlighting its widespread health implications.
CLINICAL APPLICATIONS AND THERAPEUTIC STRATEGIES
Dr. Johnson advocates for lowering uric acid levels, particularly when they exceed 5.5 mg/dL. While allopurinol is a common treatment, its use requires careful consideration of potential side effects, especially in certain ethnic groups. Restricting fructose intake, particularly from sweetened beverages, and ensuring adequate water consumption are key dietary recommendations. The potential for fructokinase inhibitors in treating conditions like fatty liver disease shows promise for future therapeutic interventions.
UNDERSTANDING THE 'BIG FOUR' CARBOHYDRATES AND FRUIT CONSUMPTION
Beyond refined sugars, highly glycemic carbohydrates like bread, potatoes, chips, and rice can also contribute to fructose production in the body, especially if the enzyme aldose reductase is induced by previous sugar intake. While whole fruits offer beneficial nutrients that can mitigate some negative effects, excessive consumption, particularly of high-fructose fruits like grapes or large apples, can still lead to increased uric acid and metabolic problems. Moderate consumption of fruits like berries, kiwis, and limes is generally advised.
Mentioned in This Episode
●Supplements
●Companies
●Organizations
●Books
●Concepts
●People Referenced
Fructose and Metabolic Health: Quick Guide
Practical takeaways from this episode
Do This
Avoid This
Common Questions
The conventional view that high blood pressure is caused solely by the amount of salt is evolving. Dr. Johnson explains that it's more about salt concentration in the blood (osmolality). When you eat salty foods without sufficient water, serum sodium rises, acutely increasing blood pressure. This effect can be blocked by drinking water with the salt, preventing the serum sodium spike.
Topics
Mentioned in this video
Dr. Johnson has been extensively funded by the NIH and has received its most prestigious grants.
A popular science magazine where Dr. Johnson and colleagues published a layperson's version of their research on the uricase mutation.
A leading scientific journal where Dr. Johnson frequently publishes his research, including a recent paper on cancer and fructose.
The Food and Drug Administration, mentioned in the context of drug safety and concerns about cardiovascular risks with febuxostat.
The institution where Dr. Johnson is a professor of medicine.
A prestigious medical journal where Dr. Johnson frequently publishes his research.
A foundation Dr. Johnson has worked with in local school programs to teach children about food labels and sugar content.
An enzyme pathway that, when stimulated by fructose metabolism leading to ATP and phosphate depletion, promotes fat storage, insulin resistance, and eventually diabetes.
An artificial sweetener, generally considered safer than regular sugar at typical doses, although there are some historical concerns about its safety.
An animal that lives in low-oxygen burrows and uses fructose production as a survival mechanism by switching from mitochondrial metabolism to glycolysis.
An artificial sweetener, mentioned in the context of safety debates similar to aspartame.
The name of the very first fossil apes that appeared in West Africa around 22 million years ago.
Molecules measured in orangutan urine to demonstrate impaired fat oxidation during periods of high fruit intake.
A rare genetic condition where individuals are born without active fructokinase, making them almost immune to the metabolic harms of sugar.
An enzyme that converts glucose to fructose, induced by high glucose levels, especially in obese individuals or diabetics, leading to endogenous fructose production even on a fructose-free diet.
An artificial sweetener used by Dr. Johnson for baking at home to reduce sugar content, despite still being high-carb.
A pain medication historically associated with increased cardiovascular risk, used as an analogy to describe the flawed clinical trial comparing allopurinol and febuxostat.
A xanthine oxidase inhibitor used to lower uric acid, which can also block metabolic syndrome effects in animals and shows promise for human conditions like hypertension and kidney disease.
A drug used to treat diabetes, which works by stimulating the AMPK pathway.
A class of drugs being developed to block fructose metabolism, with one from Pfizer currently in Phase 3 trials for fatty liver treatment.
Another xanthine oxidase inhibitor, compared to allopurinol in a clinical trial where it showed increased cardiovascular events, raising FDA concerns.
Professor of Medicine in the Department of Nephrology at the University of Colorado, prolific author, and expert on fructose metabolism.
A researcher at the Natural History Museum in London who studies fossil apes and collaborated with Johnson on the uricase mutation research.
A famous physician from the 1890s who, in his book 'Principles and Practice of Medicine,' noted sugar as a major risk factor for gout.
Mentioned by the host as a previous podcast guest who has discussed fructose and glucose, indicating his work is known to the audience.
An anthropologist who studied orangutans and showed how their fruit consumption during masting seasons led to fat storage and impaired fat oxidation.
More from Peter Attia MD
View all 258 summaries
135 min381‒Alzheimer’s disease in women: how hormonal transitions impact the brain, new therapies, & more
9 minIs Industrial Processing the Real Problem With Seed Oils? | Layne Norton, Ph.D.
13 minCooking with Lard vs Seed Oils | Layne Norton, Ph.D.
146 min380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats?
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free